{
  "name": "Ixi Wellness Dallas Llc",
  "credentials": "",
  "specialty": "Clinical Laboratory",
  "city": "Houston",
  "state": "TX",
  "entity_type": "Organization",
  "yearly_payments": [
    {
      "year": 2021,
      "total_payments": 52625.0,
      "total_services": 1001,
      "total_beneficiaries": 2,
      "avg_submitted": 157.72,
      "avg_paid": 52.57
    },
    {
      "year": 2022,
      "total_payments": 34170.37,
      "total_services": 685,
      "total_beneficiaries": 4,
      "avg_submitted": 150.09,
      "avg_paid": 49.88
    },
    {
      "year": 2023,
      "total_payments": 7596595.44,
      "total_services": 645969,
      "total_beneficiaries": 1,
      "avg_submitted": 12.0,
      "avg_paid": 11.76
    }
  ],
  "overall": {
    "total_payments": 7683390.81,
    "total_services": 647655,
    "total_beneficiaries": 7,
    "avg_markup_ratio": 1.04,
    "years_active": 3
  },
  "top_procedures": [
    {
      "code": "K1034",
      "description": "Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count",
      "services": 645969,
      "payments": 7596595.44,
      "avg_markup": 1.02
    },
    {
      "code": "U0003",
      "description": "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r",
      "services": 846,
      "payments": 63450.0,
      "avg_markup": 3.0
    },
    {
      "code": "U0005",
      "description": "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within",
      "services": 726,
      "payments": 18130.0,
      "avg_markup": 3.0
    },
    {
      "code": "U0004",
      "description": "2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r",
      "services": 51,
      "payments": 3758.25,
      "avg_markup": 3.05
    },
    {
      "code": "G2023",
      "description": "Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",
      "services": 63,
      "payments": 1457.12,
      "avg_markup": 3.03
    }
  ]
}